References
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10–29
- Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998–2002: results of population-based cancer registry. Cancer Epidemiol 2011;35:e42–e47
- Narang AS, Desai DS. Anticancer drug development. In: Lu Y, Mahato RI, eds. Pharmaceutical perspectives of cancer therapeutics. New York: Springer Science; 2009:49–93
- Lacy A, O’Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 2004;10:3797–3811
- Askari M, Sahebkar A, Iranshahi M. Synthesis and purification of 7-prenyloxycoumarins and herniarin as bioactive natural coumarins. Iran J Basic Med Sci 2009;12:63–69
- Barthomeuf C, Lim S, Iranshahi M, Chollet P. Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis. Phytomedicine 2008;15:103–111
- Iranshahi M, Askari M, Sahebkar A, Hadjipavlou-Litina D. Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. DARU 2009;17:99–103
- Soltani F, Mosaffa F, Iranshahi M, et al. Evaluation of antigenotoxicity effects of umbelliprenin on human peripheral lymphocytes exposed to oxidative stress. Cell Biol Toxicol 2009;25:291–296
- Khaghanzadeh N, Mojtahedi Z, Ramezani M, et al. Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells. DARU 2012;20:69
- Iranshahi M, Sahebkar A, Takasaki M, et al. Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. Eur J Cancer Prev 2009;18:412–415
- Shahverdi AR, Saadat F, Khorramizadeh MR, et al. Two matrix metalloproteinases inhibitors from Ferula persica var. persica. Phytomedicine 2006;13:712–717
- Elliott RL, Blobe GC. Role of transforming growth factor Beta in human cancer. J Clin Oncol 2005;23:2078–2093
- Karanikas V, Speletas M, Zamanakou M, et al. Foxp3 expression in human cancer cells. J Transl Med 2008;6:19--26
- Wang R, Lu M, Zhang J, et al. Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer. J Exp Clin Cancer Res 2011;30:62--70
- Iclozan C, Gabrilovich DI. Recent advances in immunotherapy of lung cancer. J Lung Cancer 2012;11:1–11
- Liu LN, Shivakumar R, Allen C, Fratantoni JC. Delivery of whole tumor lysate into dendritic cells for cancer vaccination. Methods Mol Biol 2008;423:139–153
- Akhila JS, Deepa S, Alwar MC. Acute toxicity studies and determination of median lethal dose. Curr Sci 2007;93:917–920
- Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989;24:148–154
- Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006;7:85
- Ciszak L, Kosmaczewska A, Werynska B, et al. Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer. Oncol Rep 2009;21:173–184
- Tanaka T, Sugiura H, Inaba R, et al. Immunomodulatory action of citrus auraptene on macrophage functions and cytokine production of lymphocytes in female BALB/c mice. Carcinogenesis 1999;20:1471–1476
- Ferrante JV, Ferrante A. Novel role of lipoxygenases in the inflammatory response: promotion of TNF mRNA decay by 15-hydroperoxyeicosatetraenoic acid in a monocytic cell line. J Immunol 2005;174:3169–3172
- Pidgeon GP, Lysaght J, Krishnamoorthy S, et al. Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 2007;26:503–524
- Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012;30:531–564
- Li C, Yang W, Gai X, et al. Foxp3 overexpression decreases sensitivity to chemotherapy in mouse Lewis lung cancer cells. Mol Med Report 2012;6:977–982
- Santibanez JF, Guerrero J, Quintanilla M, et al. Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Commun 2002;296:267–273
- Ho MY, Tang SJ, Sun KH, Yang W. Immunotherapy for lung cancers. J Biomed Biotechnol 2011;2011:250860--250870
- Han S, Asoyan A, Rabenstein H, et al. Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery. Proc Natl Acad Sci USA 2010;107:20453–20458
- Cope A, Le Friec G, Cardone J, Kemper C. The Th1 life cycle: molecular control of IFN-gamma to IL-10 switching. Trends Immunol 2011;32:278–286
- Khorramizadeh MR, Esmail-Nazari Z, Zarei-Ghaane Z, et al. Umbelliprenin-coated Fe3O4 magnetite nanoparticles: antiproliferation evaluation on human Fibrosarcoma cell line (HT-1080). Mat Sci Eng C Mater 2010;30:1038–1042